Theratechnologies Explores Potential Sale
Deal News | Apr 16, 2025 | Globenewswire
Theratechnologies Inc., a commercial-stage biopharmaceutical company, has announced an evaluation of a potential sale following interest from Future Pak. The Board of Directors has authorized a special committee comprising independent directors to oversee this process, engaging Barclays and Fasken as advisors, with the addition of Raymond James and Norton Rose Fulbright as independent advisors. While the proposal for acquisition is under consideration, the company assures stakeholders that operations will continue as normal. They have also cautioned that there is no guarantee a transaction will occur, and investors are warned of risks inherent in the process. Theratechnologies will not provide further updates unless legally required.
Sectors
- Biopharmaceuticals
- Mergers & Acquisitions
Geography
- Canada – Theratechnologies is headquartered in Montreal, which situates the primary geographic focus of the article in Canada.
Industry
- Biopharmaceuticals – Theratechnologies is a commercial-stage biopharmaceutical company focused on innovative therapies, which makes this the core industry of the article.
- Mergers & Acquisitions – The potential sale and evaluation by a special committee with involvement of financial and legal advisors classify this article under M&A.
Financials
- Not Disclosed – The financial details of the potential acquisition proposal from Future Pak are not disclosed in the article.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Theratechnologies Inc. | Target Company | Company | A commercial-stage biopharmaceutical company focused on innovative therapies. |
| Future Pak | Potential Acquirer | Company | An entity interested in acquiring Theratechnologies, though not detailed in the article. |
| Barclays | Financial Advisor | Company | Engaged by Theratechnologies for financial advisory services in the potential sale process. |
| Fasken | Legal Advisor | Company | Legal advisory firm engaged by Theratechnologies. |
| Raymond James | Independent Financial Advisor | Company | Hired as an independent financial advisor to assist in the evaluation process. |
| Norton Rose Fulbright | Independent Legal Advisor | Company | Engaged as an independent legal advisor for the potential sale process. |
| Philippe Dubuc | Senior Vice President and CFO of Theratechnologies | Person | Contact for investor inquiries at Theratechnologies. |
| Julie Schneiderman | Senior Director, Communications & Corporate Affairs | Person | Contact for media inquiries at Theratechnologies. |